Abstract
A Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have